Loading...
NASDAQ: MEDP
Medpace Holdings, Inc.
Healthcare · Medical - Diagnostics & Research
Market Cap
$12.95B
52w High
$628.92
52w Low
$250.05
P/E
28.62
Volume
126.06K
Outstanding Shares
28.38M
Company profile
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
CEOAugust James Troendle
SectorHealthcare
IndustryMedical - Diagnostics & Research
Employees5,900
IPO dateAug 11, 2016
Valuation
Forward P/E—
EV/EBITDA27.97
Enterprise value$15.95B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth32.03%
Gross margin30.06%▼3.40%vs FY2024
Operating margin21.14%▼0.22%vs FY2024
ROE98.27%▲100.61%vs FY2024
Analyst consensus
RatingHold
Target price$534.17▲17.04%
4
Buy
12
Hold
1
Sell
⚠ Analyst ratings tend to be lagging indicators — upgrades often follow price gains rather than precede them. Use as one signal among many.
Earnings
Last 3 reported quarters plus the next estimate. Switch into compare mode to inspect one metric year-over-year.
Next report
Apr 20, 2026
View
EPS
Actual vs estimate by quarter
Q3'25
ActualEst.
$3.10
$2.98
Q4'25
ActualEst.
$3.86
$3.53
Q1'26
ActualEst.
$4.67
$4.18
Q2'26
Next Est.
—
Revenue
Actual vs estimate by quarter
Q3'25
ActualEst.
$603.31M
$538.77M
Q4'25
ActualEst.
$659.9M
$641M
Q1'26
ActualEst.
$708.45M
$679.07M
Q2'26
Next Est.
—